Genetic identification of cytomegaloviruses in a rural population of Côte d'Ivoire

Virology Journal

Volumn 12, Issue 1, 2015, Pages

  Anoh, Augustin Etile ^a   Akoua Koffi, Chantal ^a   Couacy Hymann, Emmanuel ^b   Pauly, Maude ^c,d   Schubert, Grit ^c   Mossoun, Arsène ^b,e   Weiss, Sabrina ^c,f,g   Leendertz, Siv Aina J ^c   Jarvis, Michael A ^h   Leendertz, Fabian H ^c   Ehlers, Bernhard ^c  

^a Department of Anthropology and Sociology   (Côte d’Ivoire)

^b LANADA Laboratoire Central de Pathologie Animale   (Côte d’Ivoire)

^c ROBERT KOCH INSTITUTE   (Germany)

^d LUXEMBOURG INSTITUTE OF HEALTH   (Luxembourg)

^e UNIVERSITÉ FÉLIX HOUPHOUËT BOIGNY   (Côte d’Ivoire)

^f EUROPEAN CENTRE FOR DISEASE PREVENTION AND CONTROL ECDC   (Sweden)

^g PUBLIC HEALTH ENGLAND   (United Kingdom)

^h UNIVERSITY OF PLYMOUTH   (United Kingdom)

Author keywords

Bushmeat; Colobus; Cytomegalovirus; C te d'Ivoire; Glycoprotein B; Herpesvirus; Human; Monkey; Zoonosis

Indexed keywords

GLYCOPROTEIN B; GLYCOPROTEIN B, SIMPLEXVIRUS; VIRUS ENVELOPE PROTEIN;

ARTICLE; CONTROLLED STUDY; COTE D'IVOIRE; CYTOMEGALOVIRUS; FECES ANALYSIS; GENETIC IDENTIFICATION; HUMAN; HUMAN CYTOMEGALOVIRUS; NONHUMAN; NORMAL HUMAN; ORAL BIOPSY; POLYMERASE CHAIN REACTION; PRIMATE; RURAL POPULATION; SEQUENCE ANALYSIS; VIRUS SHEDDING; VIRUS STRAIN; CLASSIFICATION; CYTOMEGALOVIRUS INFECTIONS; DNA SEQUENCE; FECES; GENETIC VARIATION; GENETICS; GENOTYPE; ISOLATION AND PURIFICATION; MOLECULAR EPIDEMIOLOGY; MOUTH; PREVALENCE; VIROLOGY;

COTE D'IVOIRE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FECES; GENETIC VARIATION; GENOTYPE; HUMANS; MOLECULAR EPIDEMIOLOGY; MOUTH; PREVALENCE; RURAL POPULATION; SEQUENCE ANALYSIS, DNA; VIRAL ENVELOPE PROTEINS;

EID: 84943225747     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/s12985-015-0394-1     Document Type: Article

References (48)

1. Mocarski ES, Shenk T, Pass RF. Cytomegaloviruses. 5th ed. Philadelphia, PA: Lippincott Williams; 2007.
2. Russell MY, Palmer A, Michaels MG. Cytomegalovirus infection in pediatric immunocompromised hosts. Infect Disord Drug Targets. 2011;11:437-48.
3. Jabs DA. AIDS and ophthalmology, 2008. Arch Ophthalmol. 2008;126:1143-6.
4. Lischka P, Zimmermann H. Antiviral strategies to combat cytomegalovirus infections in transplant recipients. Curr Opin Pharmacol. 2008;8:541-8.
5. Dolan A, Cunningham C, Hector RD, Hassan-Walker AF, Lee L, Addison C, et al. Genetic content of wild-type human cytomegalovirus. J Gen Virol. 2004;85:1301-12.
6. Rasmussen L, Geissler A, Winters M. Inter- and intragenic variations complicate the molecular epidemiology of human cytomegalovirus. J Infect Dis. 2003;187:809-19.
7. Kashiwagi Y, Kawashima H, Matsuura K, Sasamoto M, Takekuma K, Hoshika A, et al. Clinical characteristics and gB genotype of cytomegalovirus infection in Japan. In Vivo. 2002;16:447-50.
8. Pignatelli S, Dal Monte P, Rossini G, Landini MP. Genetic polymorphisms among human cytomegalovirus (HCMV) wild-type strains. Rev Med Virol. 2004;14:383-410.
9. Novak Z, Ross SA, Patro RK, Pati SK, Kumbla RA, Brice S, et al. Cytomegalovirus strain diversity in seropositive women. J Clin Microbiol. 2008;46:882-6.
10. Grosjean J, Hantz S, Cotin S, Baclet MC, Mengelle C, Trapes L, et al. Direct genotyping of cytomegalovirus envelope glycoproteins from toddler's saliva samples. J Clin Virol. 2009;46:S43-8.
11. Zipeto D, Hong C, Gerna G, Zavattoni M, Katzenstein D, Merigan TC, et al. Geographic and demographic differences in the frequency of human cytomegalovirus gB genotypes 1-4 in immunocompromised patients. Aids Research and Human Retroviruses. 1998;14:533-6.
12. Schopfer K, Lauber E, Krech U. Congenital cytomegalovirus infection in newborn infants of mothers infected before pregnancy. Arch Dis Child. 1978;53:536-9.
13. Diafouka F, Foulongne V, Hauhouot-Attoungbre ML, Monnet D, Segondy M. Cytomegalovirus DNA in semen of men seeking fertility evaluation in Abidjan, Cote d'Ivoire. Eur J Clin Microbiol Infect Dis. 2007;26:295-6.
14. Haller L, Schopfer K. [Occurrence of cytomegalic disease, hepatitis (HBs antigens), and toxoplasmosis in 300 schoolchildren living in the tropical forest zone]. Acta Trop. 1980;37:123-9.
15. Beyari MM, Hodgson TA, Kondowe W, Molyneux EM, Scully C, Porter SR, et al. Inter- and intra-person cytomegalovirus infection in Malawian families. J Med Virol. 2005;75:575-82.
16. Kaye S, Miles D, Antoine P, Burny W, Ojuola B, Kaye P, et al. Virological and immunological correlates of mother-to-child transmission of cytomegalovirus in the Gambia. J Infect Dis. 2008;197:1307-14.
17. van der Sande MAB, Kaye S, Miles DJC, Waight P, Jeffries DJ, Ojuola OO, et al. Risk Factors for and Clinical Outcome of Congenital Cytomegalovirus Infection in a Peri-Urban West-African Birth Cohort. Plos One 2007, 2: E492.
18. Brantsaeter AB, Johannessen A, Holberg-Petersen M, Sandvik L, Naman E, Kivuyo SL, et al. Cytomegalovirus viremia in dried blood spots is associated with an increased risk of death in HIV-infected patients: a cohort study from rural Tanzania. Int J Infect Dis. 2012;16:E879-85.
19. Gogarten JF, Akoua-Koffi C, Calvignac-Spencer S, Leendertz SA, Weiss S, Couacy-Hymann E, et al. The ecology of primate retroviruses - an assessment of 12 years of retroviral studies in the Tai national park area, Cote dIvoire. Virology. 2014;460(461):147-53.
20. Peeters M, Courgnaud V, Abela B, Auzel P, Pourrut X, Bibollet-Ruche F, et al. Risk to human health from a plethora of simian immunodeficiency viruses in primate bushmeat. Emerg Infect Dis. 2002;8:451-7.
21. Wolfe ND. Bushmeat Hunting, Deforestation, and Prediction of Zoonotic Disease Emergence. Emerg Infect Dis. 2005;11:1822-7.
22. Jones KE, Patel NG, Levy MA, Storeygard A, Balk D, Gittleman JL, et al. Global trends in emerging infectious diseases. Nature. 2008;451:990-3.
23. Gillespie TR, Nunn CL, Leendertz FH: Integrative approaches to the study of primate infectious disease: implications for biodiversity conservation and global health. Am J Phys Anthropol 2008, Suppl 47:53-69
24. Leroy EM, Gonzalez JP, Baize S. Ebola and Marburg haemorrhagic fever viruses: major scientific advances, but a relatively minor public health threat for Africa. Clin Microbiol Infect. 2011;17:964-76.
25. Liu W, Li Y, Learn GH, Rudicell RS, Robertson JD, Keele BF, et al. Origin of the human malaria parasite Plasmodium falciparum in gorillas. Nature. 2010;467:420-5.
26. Sharp PM, Hahn BH. Origins of HIV and the AIDS pandemic. Cold Spring Harb Perspect Med. 2011;1:a006841.
27. Calvignac-Spencer S, Adjogoua EV, Akoua-Koffi C, Hedemann C, Schubert G, Ellerbrok H, et al. Origin of human T-lymphotropic virus type 1 in rural Cote d'Ivoire. Emerg Infect Dis. 2012;18:830-3.
28. Brashares JS, Arcese P, Sam MK, Coppolillo PB, Sinclair AR, Balmford A. Bushmeat hunting, wildlife declines, and fish supply in West Africa. Science. 2004;306:1180-3.
29. Refisch J, Kone I. Impact of commercial hunting on monkey populations in the Tai region, Cote d'Ivoire. Biotropica. 2005;37:136-44.
30. Mossoun A, Pauly M, Akoua-Koffi C, Couacy-Hymann E, Leendertz SA, Anoh AE, et al. Contact to non-human primates and risk factors for zoonotic disease emergence in the Taï region, Côte d'Ivoire. EcoHealth 2015, in press.
31. Murthy S, Couacy-Hymann E, Metzger S, Nowak K, De Nys H, Boesch C, et al. Absence of frequent herpesvirus transmission in a nonhuman primate predator-prey system in the wild. J Virol. 2013;87:10651-9.
32. Pauly M, Akoua-Koffi C, Buchwald N, Schubert G, Weiss S, Couacy-Hymann E, et al. Adenovirus in Rural Cote D'Ivoire: High Diversity and Cross-Species Detection. Ecohealth 2015; May 20. [Epub ahead of print]
33. Pauly M, Hoppe E, Mugisha L, Petrzelkova K, Akoua-Koffi C, Couacy-Hymann E, et al. High prevalence and diversity of species D adenoviruses (HAdV-D) in human populations of four Sub-Saharan countries. Virol J. 2014;11:25.
34. Hoppe E, Pauly M, Gillespie TR, Akoua-Koffi C, Hohmann G, Fruth B, et al. Multiple cross-species transmission events of human adenoviruses (HAdV) during hominine evolution. Mol Biol Evol. 2015;32:2072-84.
35. Leendertz FH, Deckers M, Schempp W, Lankester F, Boesch C, Mugisha L, et al. Novel cytomegaloviruses in free-ranging and captive great apes: phylogenetic evidence for bidirectional horizontal transmission. J Gen Virol. 2009;90:2386-94.
36. Ehlers B, Kuchler J, Yasmum N, Dural G, Voigt S, Schmidt-Chanasit J, et al. Identification of novel rodent herpesviruses, including the first gammaherpesvirus of Mus musculus. J Virol. 2007;81:8091-100.
37. Glauser DL, Milho R, Frederico B, May JS, Kratz AS, Gillet L, et al. Glycoprotein B cleavage is important for murid herpesvirus 4 to infect myeloid cells. J Virol. 2013;87:10828-42.
38. Refisch J, Kone I. Market hunting in the Tai Region, Cote d'Ivoire and implications for monkey populations. Int J Primatol. 2005;26:621-9.
39. Kozireva S, Nemceva G, Danilane I, Pavlova O, Blomberg J, Murovska M. Prevalence of blood-borne viral infections (cytomegalovirus, human herpesvirus-6, human herpesvirus-7, human herpesvirus-8, human T-cell lymphotropic virus-I/II, human retrovirus-5) among blood donors in Latvia. Ann Hematol. 2001;80:669-73.
40. Urushibara N, Kwon KW, Takahashi TA, Sekiguchi S. Human cytomegalovirus DNA is not detectable with nested double polymerase chain reaction in healthy blood donors. Vox Sang. 1995;68:9-14.
41. Bitsch A, Kirchner H, Dupke R, Bein G. Failure to detect human cytomegalovirus DNA in peripheral blood leukocytes of healthy blood donors by the polymerase chain reaction. Transfusion. 1992;32:612-7.
42. Smith KL, Kulski JK, Cobain T, Dunstan RA. Detection of cytomegalovirus in blood donors by the polymerase chain reaction. Transfusion. 1993;33:497-503.
43. Tann CJ, Nkurunziza P, Nakakeeto M, Oweka J, Kurinczuk JJ, Were J, et al. Prevalence of Bloodstream Pathogens Is Higher in Neonatal Encephalopathy Cases vs. Controls Using a Novel Panel of Real-Time PCR Assays. Plos One. 2014;9:e97259.
44. Holmes EC. Evolutionary history and phylogeography of human viruses. Annu Rev Microbiol. 2008;62:307-28.
45. Skinner GR, Ahmad A, Davies JA. The infrequency of transmission of herpesviruses between humans and animals; postulation of an unrecognised protective host mechanism. Comp Immunol Microbiol Infect Dis. 2001;24:255-69.
46. Jurak I, Brune W. Induction of apoptosis limits cytomegalovirus cross-species infection. EMBO J. 2006;25:2634-42.
47. Lafemina RL, Hayward GS. Differences in cell-type-specific blocks to immediate early gene expression and DNA replication of human, simian and murine cytomegalovirus. J Gen Virol. 1988;69(Pt 2):355-74.
48. Griffiths P, Plotkin S, Mocarski E, Pass R, Schleiss M, Krause P, et al. Desirability and feasibility of a vaccine against cytomegalovirus. Vaccine. 2013;31 Suppl 2:B197-203.